CClinicalTrials.gg
CompletedNCT02407743TEMPOSUpdated Jan 19, 2021

TEMporal PostOperative Pain Signatures

An observational study in Pain, Postoperative, sponsored by University of Florida. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-01-19.

Sponsored by University of Florida · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
428
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this research study is to determine what causes pain after surgery to increase or decrease over time.

Read the detailed description

Before surgery, study participants will be asked questions about age, gender, race/ethnicity, annual income, and education level. Study participants will also be questioned regarding prior pain experiences, their mood and how they think about pain. A small test tube of blood, a cheek swab or a saliva sample will be taken to see what genetic differences may influence individuals pain after surgery.

After surgery, study participants will be asked questions about their pain intensity while in the hospital. Additional information will be collected about the effects of pain medicine, and their recovery from surgery.

Following discharge from the hospital, study participants will be contacted monthly to confirm continued communication. Study participants will also be contacted six months after surgery, and asked to complete a final survey about their pain after surgery.

02

Conditions studied

  • Pain, Postoperative

Browse trials for

Keywords

  • postoperative pain
  • surgery
  • pain resolution
  • pain intensity
  • persistent postsurgical pain
  • pain-related genes
  • analgesic
03

In context

Pain, Postoperative

5,089 studies on the registry are indexed under Pain, Postoperative; 1,137 are open to participants now.

This study's enrollment of 428 is above the median of 102 across 607 observational studies indexed under Pain, Postoperative.

Browse Pain, Postoperative studies →

Lead sponsor

University of Florida is the lead sponsor of 1,254 studies on the registry; 201 are open to participants now.

Of its 170 completed or terminated interventional studies of FDA-regulated products, 136 (80%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients scheduled for surgery will be invited to participate in this study.

Inclusion criteria

  • 18 years of age or older
  • anticipated length of hospital stay of 72 hours or greater
  • expected post-operative survival greater than 6 months

Exclusion criteria

Exclusion Criteria:

  • \< 18 years of age
  • anticipated need for prolonged post-operative intubation (greater than 24 hours)
  • urgent or emergent surgical procedure
  • inability to understand or participate in questionnaires, surveys or data collection
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
428 participants (actual)
Patient registry
No

Groups and cohorts

  • Surgical patients' clinical progression

    Patients undergoing non-ambulatory surgery will be asked questions and complete surveys in an effort to characterize postoperative pain experience profiles. A blood sample will be obtained for genetic markers exploring a variety of pain-related genes.

    Behavioral: Surgical patients' clinical progression · Genetic: Genetic markers

Interventions

  • BehavioralSurgical patients' clinical progression

    Study the dynamic nature of pain

  • GeneticGenetic markers

    Research variants in genes related to pain sensitivity, analgesic sensitivity and opioid response

06

What researchers measure

Primary outcomes

  1. Measure postoperative pain scores change with respect to time

    Pain scores will be measured using previously established pain scale and Questionnaire

    Time frame: up to 7 days

Secondary outcomes

  1. Measure variables that contribute to postoperative pain scores

    Variables: clinical, biological, psychological, and social factors

    Time frame: up to 6 months

  2. Measure timing patterns that may influence development of persistent postsurgical pain (PPP)

    Different patterns of pain analgesia-pain cycles

    Time frame: up to 6 months

  3. Genetic testing

    Specific single nucleotide polymorphisms

    Time frame: up to 1 day

07

Study locations

1 site
  • UF Health
    Gainesville, Florida 32610-3003, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 19, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02407743
Lead sponsor
University of Florida
Collaborators
National Institute of General Medical Sciences (NIGMS)
Responsible party
Sponsor
First posted
Apr 3, 2015
Start date
Aug 2015
Primary completion
Aug 2020
Completion
Aug 2020
Last update
Jan 19, 2021

Study contacts

Patrick J Tighe, MD
principal investigator · Assistant Professor of Anesthesiology and Program Director, Perioperative Analytics Group Joint Assistant Professor of Orthopedics

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion